Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Morphological aspects related to long-term functional improvement of the retina in the 4 years following rAAV-mediated gene transfer in the RPE65 null mutation dog.

Advances in experimental medicine and biology - 1 Jan 2008

Narfström Kristina, Seeliger Mathias, Lai Chooi-May, Vaegan, Katz Martin, Rakoczy Elizabeth P, Remé Charlotte

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus
Share to Dependovirus
Share to Dog Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electroretinography

Share to Eye Proteins

Share to Fundus Oculi

Share to Gene Transfer Techniques

Share to Retina

Source

Identifiers

PMID: 18188938
DOI: 10.1007/978-0-387-74904-4_15

Genes

RPE65

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Morphological aspects related to long-term functional improvement of the retina in the 4 years following rAAV-mediated gene transfer in the RPE65 null mutation dog.PMID 18188938Read ↗

Assessment of structure and function over a 3-year period after gene transfer in RPE65-/- dogs.Semantic proximity Read ↗

Gene therapy in the second eye of RPE65-deficient dogs improves retinal functionSemantic proximity Read ↗

Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.Semantic proximity Read ↗

Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epitheliumSemantic proximity Read ↗

RPE65 gene therapy slows cone loss in Rpe65-deficient dogsSemantic proximity Read ↗

Long-Term Structural Outcomes of Late-Stage RPE65 Gene TherapySemantic proximity Read ↗

A Comprehensive Study of the Retinal Phenotype of Rpe65-Deficient Dogs.Semantic proximity Read ↗

The use of canine models of inherited retinal degeneration to test novel therapeutic approaches.Semantic proximity Read ↗

Large Animal Models of Inherited Retinal Degenerations: A Review.Semantic proximity Read ↗

AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient DogsSemantic proximity Read ↗

Successful Gene Therapy in Older Rpe65-Deficient Dogs Following Subretinal Injection of an Adeno-Associated Vector Expressing <i>RPE65</i>Semantic proximity Read ↗

Long-term effect of gene therapy on Leber's congenital amaurosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.